ALOFISEL darvadstrocel Cx-601 On 14 December 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Alofisel, intended for the treatment of complex perianal fistulas in patients with Crohn’s disease. As Alofisel is an advanced therapy medicinal product, the […]
via ALOFISEL, darvadstrocel Cx-601 — New Drug Approvals
Share this:
